All members

Carola Krause

Committee members:

  • Raquel Billiones
  • Surayya Taranum
  • Archana Nagarajan
  • Blanca Gomez

SIG supporting members:

  • Mariana Rickmann
  • Carolina Rojido
  • Lutgart Opstaele
  • Andrea Rossi
  • Kimi Uegaki
  • Elia Sala
  • Claire Beeby
  • Louisa Marcombes
  • Kate Silverthorne
  • Daniela Nakagawa

SUS SIG Membership

If you are interested in joining the SUS SIG, please contact the SIG Chair:

SUS SIG Meetings

The EMWA SUS SIG meets virtually every month. If you are interested in joining our discussions, you can send a mail to

Upcoming Meetings

  • 23 September 2021; 19:00 CEST
  • 21 October 2021; 19:00 CEST
  • 25 November 2021; 19:00 CET
  • 16 December 2021; 19:00 CET

SUS SIG objectives

The Sustainability Special Interest Group (SUS-SIG) aims to bring sustainability goals into EMWA as an organisation and help disseminate information for the medical writers on being more sustainable as industry professionals. Furthermore, we want to raise awareness of industry standards (pharma, medical devices, etc.) on sustainability goals.

Latest news and activities

Medical Writing Journal:

In the MW journal's March issue (Volume 30/Issue 1/2021/, we introduced the section The Crofter – Sustainable Communications. Kimi Uegaki is taking on the Section Editor role. Thank you, Kimi!

Social Media:

The SUS SIG is active on EMWA's LinkedIn page. You can find us via #EMWASUSSIG.

Meet & Share:

We will have a Meet & Share session on the following topic: The EU GREEN DEAL and its impact on the healthcare industry in June 2021. If you would like to participate, please contact

Subgroups and topics

EMWA as UN Sustainability Partner Organisation

EMWA's Ecological Footprint

The Healthcare Industry & Sustainability

Medical Communications & Sustainability

  • Subgroup Head: Archana

    Members: Raquel, Kimi, Blanca, Daniela

    Regulatory Writing in the Context of Sustainability

    We continuously investigate how regulatory bodies implement the United Nations Sustainable Development Goals. Through webinars & EPDC approved workshops, we aim to provide information on regulatory guideline updates and on how these document should be written and updated. Currently, we focus on the following regulatory topics:

    • Guideline on the environmental risk assessment of medicinal products for human use (EMEA/CHMP/CWP/4447/00 Corr 2),
    • Healthcare Waste Management / Circular Economy (EU-HCWM project).

    We currently team up with EMWAs Veterinary Medical Writing and Pharmacovigilance SIGs to provide you with in-depth insights on those topics.

    Position Statement on the Fact-Checking Role of Medical Writers & Communicators

    We aim to publish a Position Statement on Fact-Checking following the recommendation of the WHO's Information Network for Epidemics (EPI-WIN), the Code of Principles of The International Fact-Checking Network (IFCN), among others. This document will equip medical writers with a checklist to adhere to when looking for information and writing for their audiences.

    The Role of Medical Writers & Communicators in Adapting the FAIR Data Principles

    We believe that Medical Writers & Communicators have a role in familiarising and adapting the FAIR data principles. FAIR stands for findable-accessible-interoperable-reusable data, hence, how data is shared following the completion of a research study. This is aligned with the need to reduce and prevent research waste, such as unnecessary duplication of efforts. The requirement for explicit data sharing plans also reflects the recognition that the traditional silo-culture surrounding data management has kept data hidden, and opportunities to adequately and accurately inform new studies have been foregone.

    FAIR data principles lead to creating data systems in which all data and metadata are machine-readable and GPDR-compliant and allow analyses to occur without the movement of data from their original storage locations. These principles are advocated by organisations such as the EMA and the Heads of Medicines Agencies (HMA), European Commission, and the WHO.